April 24, 2018
Medical device maker C.R. Bard on Monday moved for a new trial after being hit with a $3.6 million verdict last month in a multidistrict litigation test trial over the safety of its clot-stopping vein filters, telling an Arizona federal court the decision was "inconsistent" and rested on flimsy evidence.
March 30, 2018
A Phoenix federal jury awarded $2 million in compensatory damages and $2 million in punitive damages on Friday to a woman who said a clot-stopping vein filter manufactured by C.R. Bard Inc. broke apart in her body, finding the device maker responsible for 80 percent of the harm for a total of $3.6 million in damages.
March 29, 2018
A Phoenix federal jury began deliberations Thursday in the first bellwether trial in multidistrict litigation over claims that device maker Bard's clot-stopping vein implants splintered and migrated towards patients' hearts, after Bard closed its case by arguing evidence concerning predecessor implants and FDA warnings were red herrings.